Table of Contents Author Guidelines Submit a Manuscript
Advances in Preventive Medicine
Volume 2016, Article ID 9405105, 13 pages
http://dx.doi.org/10.1155/2016/9405105
Research Article

Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, Venezuela

1Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4004, Venezuela
2Morphologic Sciences Department and Pediatric Surgery Department, School of Medicine, University of Zulia, Maracaibo 4004, Venezuela

Received 13 March 2016; Accepted 26 May 2016

Academic Editor: Gerardo E. Guillén Nieto

Copyright © 2016 Valmore Bermudez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kasuga, “Insulin resistance and pancreatic β cell failure,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1756–1760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Costes, R. Langen, T. Gurlo, A. V. Matveyenko, and P. C. Butler, “β-Cell failure in type 2 diabetes: a case of asking too much of too few?” Diabetes, vol. 62, no. 2, pp. 327–335, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, “The top ten causes of death,” Fact Sheet No 310, 2011, http://www.who.int/mediacentre/factsheets/fs310/en/. View at Google Scholar
  4. J. P. Boyle, T. J. Thompson, E. W. Gregg, L. E. Barker, and D. F. Williamson, “Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence,” Population Health Metrics, vol. 8, p. 29, 2010. View at Publisher · View at Google Scholar
  5. M. Serrano Ríos, “Resistencia a la insulina y su implicación en múltiples factores de riesgo asociados a diabetes tipo 2,” Medicina Clínica, vol. 119, no. 12, pp. 458–463, 2002. View at Publisher · View at Google Scholar
  6. J. Rojas, V. Bermúdez, E. Leal et al., “Insulinorresistencia e hiperinsulinemia como factores de riesgo para enfermedad cardiovascular,” Archivos Venezolanos de Farmacología y Terapéutica, vol. 27, no. 1, pp. 29–39, 2008. View at Google Scholar
  7. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Bermúdez, J. Rojas, M. S. Martínez et al., “Epidemiologic behavior and estimation of an optimal cut-off point for homeostasis model assessment-2 insulin resistance: a report from a Venezuelan population,” International Scholarly Research Notices, vol. 2014, Article ID 616271, 10 pages, 2014. View at Publisher · View at Google Scholar
  9. V. Bermúdez, R. P. Marcano, C. Cano et al., “The maracaibo city metabolic syndrome prevalence study: design and scope,” American Journal of Therapeutics, vol. 17, no. 3, pp. 288–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Méndez and M. Méndez, “Estratificación social y biología humana: método Graffar modificado,” Archivos Venezolanos de Puericultura y Pediatría, vol. 49, pp. 93–104, 1986. View at Google Scholar
  11. I. Berlin, S. Lin, J. A. C. Lima, and A. G. Bertoni, “Smoking status and metabolic syndrome in the multi-ethnic study of atherosclerosis. A Cross-Sectional Study,” Tobacco Induced Diseases, vol. 10, no. 1, article 9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Baglietto, D. R. English, J. L. Hopper, J. Powles, and G. G. Giles, “Average volume of alcohol consumed, type of beverage, drinking pattern and the risk of death from all causes,” Alcohol and Alcoholism, vol. 41, no. 6, pp. 664–671, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Martín Centeno and P. Rojano Capilla, “Conceptos y anamnesis del consumo de alcohol en la consulta de Atención Primaria,” Medicina General, vol. 29, pp. 957–962, 2000. View at Google Scholar
  14. V. Berm·dez, Y. Torres, V. Apruzzese et al., “Alcohol drinking patterns in the adult population from the Maracaibo municipality, Zulia—Venezuela,” Revista Latinoamericana de Hipertensión, vol. 9, pp. 21–28, 2014. View at Google Scholar
  15. IPAQ Core Group 2005, “Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ)-Short and Long Forms,” 2015, https://www.researchgate.net/file.PostFileLoader.html?id=56f92d66615e27d49a658031&assetKey=AS%3A344600888791041%401459170662924.
  16. P. A. James, S. Oparil, B. L. Carter et al., “2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8),” The Journal of the American Medical Association, vol. 311, no. 5, pp. 507–520, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. World Health Organization, The World Health Report 2003, World Health Organization, Geneva, Switzerland, 2003, http://www.who.int/topics/obesity/en/.
  18. Health Statistics, NHANES III Reference Manuals and Reports (CDROM), Centers for Disease Control and Prevention, Hyattsville, Md, USA, 1996, http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/anthro.pdf.
  19. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  20. K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Levy, D. R. Matthews, and M. P. Hermans, “Correct homeostasis model assessment (HOMA) evaluation uses the computer program,” Diabetes Care, vol. 21, no. 12, pp. 2191–2192, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. A. R. Omran, “The epidemiologic transition: a theory of the epidemiology of population change,” Milbank Quarterly, vol. 83, no. 4, pp. 731–757, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Ruiz-Fernández, M. Espinoza, E. Barrios, and A. Reigosa, “Factores cardiometabólicos en una comunidad de Valencia, Venezuela,” Revista de Salud Pública, vol. 11, pp. 383–394, 2009. View at Google Scholar
  24. M. Querales, S. Rojas, G. Quevedo, J. Remolina, O. Mundaray, and D. Graterol, “Cintura hipertrigliceridémica y resistencia a la insulina en una comunidad rural y una urbana de Tinaquillo,” Revista Venezolana de Endocrinología y Metabolismo, vol. 12, no. 1, pp. 25–33, 2014. View at Google Scholar
  25. V. Miguel, Z. Rodríguez, L. Aponte et al., “Insulinorresistencia, obesidad y síndrome metabólico,” Cohorte CDC de Canarias en Venezuela. Salus, vol. 17, pp. 18–24, 2013. View at Google Scholar
  26. H. Schargrodsky, R. Hernández-Hernández, B. M. Champagne et al., “CARMELA: assessment of cardiovascular risk in seven Latin American Cities,” The American Journal of Medicine, vol. 121, no. 1, pp. 58–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Friedrich, B. Thuesen, T. Jrøgensen et al., “The association between IGF-I and insulin resistance: a general population study in Danish adults,” Diabetes Care, vol. 35, no. 4, pp. 768–773, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Ziaee, N. Esmailzadehha, S. Oveisi, A. Ghorbani, and L. Ghanei, “The threshold value of homeostasis model assessment for insulin resistance in Qazvin Metabolic Diseases Study (QMDS): assessment of metabolic syndrome,” Journal of Research in Health Sciences, vol. 15, no. 2, pp. 94–100, 2015. View at Google Scholar · View at Scopus
  29. H.-Q. Qu, Q. Li, A. R. Rentfro, S. P. Fisher-Hoch, and J. B. McCormick, “The definition of insulin resistance using HOMA-IR for americans of mexican descent using machine learning,” PLoS ONE, vol. 6, no. 6, Article ID e21041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. H.-Q. Qu, Q. Li, Y. Lu, C. L. Hanis, S. P. Fisher-Hoch, and J. B. Mccormick, “Ancestral effect on HOMA-IR levels quantitated in an american population of Mexican origin,” Diabetes Care, vol. 35, no. 12, pp. 2591–2593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Haffner, R. D'Agostino Jr., M. F. Saad et al., “Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study,” Diabetes, vol. 45, no. 6, pp. 742–748, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. T. M. Wallace, J. C. Levy, and D. R. Matthews, “Use and abuse of HOMA modeling,” Diabetes Care, vol. 27, no. 6, pp. 1487–1495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S. R. Preis, J. M. Massaro, S. J. Robins et al., “Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the framingham heart study,” Obesity, vol. 18, no. 11, pp. 2191–2198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Suba, “Low estrogen exposure and/or defective estrogen signaling induces disturbances in glucose uptake and energy expenditure,” Journal of Diabetes & Metabolism, vol. 4, no. 5, article 272, 2013. View at Publisher · View at Google Scholar
  35. G. Rojas, Z. Morillo, J. Salazar, L. Bello, R. Añez, and R. Varela, “Insulinorresistencia en pacientes con síndrome coronario agudo: estudio exploratorio del Hospital General del Sur de Maracaibo,” Avances Cardiológicos, vol. 34, pp. 202–216, 2014. View at Google Scholar
  36. J. Rojas, M. Chávez-Castillo, L. C. Olivar et al., “Physiologic course of female reproductive function: a molecular look into the prologue of life,” Journal of Pregnancy, vol. 2015, Article ID 715735, 21 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. V. De Tata, “Age-related impairment of pancreatic beta-cell function: pathophysiological and cellular mechanisms,” Frontiers in Endocrinology, vol. 5, article 138, 2014. View at Publisher · View at Google Scholar
  38. E. Bonora, G. Formentini, F. Calcaterra et al., “HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study,” Diabetes Care, vol. 25, no. 7, pp. 1135–1141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. J. C. Seidell and T. L. S. Visscher, “Body weight and weight change and their health implications for the elderly,” European Journal of Clinical Nutrition, vol. 54, no. 3, pp. S33–S39, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Kalantar-Zadeh, E. Streja, C. P. Kovesdy et al., “The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis,” Mayo Clinic Proceedings, vol. 85, no. 11, pp. 991–1001, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Curtis, J. Selter, and Y. Wang, “The obesity paradox body mass index and outcomes in patients with heart failure,” ACC Current Journal Review, vol. 14, no. 4, p. 36, 2005. View at Publisher · View at Google Scholar
  42. J. Sobal, B. S. Rauschenbach, and E. A. Frongillo Jr., “Marital status, fatness and obesity,” Social Science & Medicine, vol. 35, no. 7, pp. 915–923, 1992. View at Publisher · View at Google Scholar · View at Scopus
  43. A. A. Kiadaliri, M. Jafari, M.-R. Vaez Mahdavi, S. Faghihzadeh, N. Kalantari, and M. Asadi-Lari, “The prevalence of adulthood overweight and obesity in Tehran: findings from Urban HEART-2 study,” Medical Journal of the Islamic Republic of Iran, vol. 29, article 178, 2015. View at Google Scholar · View at Scopus
  44. H. Arem, S. C. Moore, A. Patel et al., “Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship,” JAMA Internal Medicine, vol. 175, no. 6, pp. 959–967, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. R. K. Nelson, J. F. Horowitz, R. G. Holleman et al., “Daily physical activity predicts degree of insulin resistance: a cross-sectional observational study using the 2003-2004 National Health and Nutrition Examination Survey,” International Journal of Behavioral Nutrition and Physical Activity, vol. 10, article 10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. “Standards of medical care in diabetes—2015: summary of revisions,” Diabetes Care, vol. 38, supplement 1, article S4, 2015. View at Publisher · View at Google Scholar
  47. N. T. Bendsen, R. Christensen, E. M. Bartels et al., “Is beer consumption related to measures of abdominal and general obesity? A systematic review and meta-analysis,” Nutrition Reviews, vol. 71, no. 2, pp. 67–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. M. R. Carnethon, S. P. Fortmann, L. Palaniappan, B. B. Duncan, M. I. Schmidt, and L. E. Chambless, “Risk factors for progression to incident hyperinsulinemia: The Atherosclerosis Risk in Communities Study, 1987–1998,” American Journal of Epidemiology, vol. 158, no. 11, pp. 1058–1067, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. S. M. Furler, A. M. Poynten, A. D. Kriketos et al., “Independent influences of central fat and skeletal muscle lipids on insulin sensitivity,” Obesity Research, vol. 9, no. 9, pp. 535–543, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. R. P. Hoffman, “Increased fasting triglyceride levels are associated with hepatic insulin resistance in caucasian but not African-American adolescents,” Diabetes Care, vol. 29, no. 6, pp. 1402–1404, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Laws and G. M. Reaven, “Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations,” Journal of Internal Medicine, vol. 231, no. 1, pp. 25–30, 1992. View at Publisher · View at Google Scholar · View at Scopus
  52. M. H. deCarvalho, A. L. Colaço, and Z. B. Fortes, “Citocinas, disfunção endotelial e resistência à insulina,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 50, no. 2, pp. 304–312, 2006. View at Publisher · View at Google Scholar
  53. D. M. Muoio and C. B. Newgard, “Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes,” Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 193–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Castillo-Nuñez and C. A. Aguilar-Salina, “Medición de la resistencia a la insulina en la práctica clínica,” Revista ALAD, vol. 5, pp. 8–10, 2015. View at Google Scholar